| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.1M | +19.6% | +71.9% |
| Cost of Revenue | $598K | +31.4% | -16.6% |
| Gross Profit | $2.5M | +17.1% | +130.4% |
| R&D Expense | $419K | +55.0% | -50.6% |
| SG&A Expense | $1.1M | +32.1% | -41.3% |
| Operating Income | $799K | -59.4% | +141.4% |
| Interest Expense | $1K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.1M | +74.5% | +449.8% |
| Current Assets | $6.3M | +33.4% | +169.1% |
| Total Assets | $10.1M | +23.9% | +44.9% |
| Current Liabilities | $3.3M | +28.2% | -30.9% |
| Total Liabilities | $3.3M | +28.0% | -31.2% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $2.3M | — | — |
| Capital Expenditures | $4K | — | — |
| Investing Cash Flow | -$677K | — | — |
| Financing Cash Flow | $1.5M | — | — |
| Free Cash Flow | $2.3M | — | — |
| -69.7% |
| -95.2% |
| Net Income | $789K | -81.5% | +7931.9% |
| EPS (Basic) | $0.14 | -82.9% | — |
| EPS (Diluted) | $0.14 | -82.9% | — |
| $5.9M |
| +21.5% |
| +43.0% |